Literature DB >> 22450508

Sex-related factors in multiple sclerosis susceptibility and progression.

Rhonda R Voskuhl1, Stefan M Gold.   

Abstract

The pathogenesis of multiple sclerosis (MS) involves complex interactions between genetic susceptibility and environmental triggers. Clinical observations suggest that the study of sex differences might provide important insight into mechanisms of pathogenesis and progression of the disease in patients. MS occurs more frequently in women than in men, indicating that sex-related factors have an effect on an individual's susceptibility to developing the condition. These factors include hormonal, genetic and environmental influences, as well as gene-environment interactions and epigenetic mechanisms. Interestingly, women do not have a poorer prognosis than men with MS despite a higher incidence of the disease and more-robust immune responses, which suggests a mechanism of resilience. Furthermore, the state of pregnancy has a substantial effect on disease activity, characterized by a reduction in relapse rates during the third trimester but an increased relapse rate in the postpartum period. However, pregnancy has little effect on long-term disability in women with MS. The unravelling of the mechanisms underlying these clinical observations in the laboratory and application of the results to the clinical setting is a unique and potentially fruitful strategy to develop novel therapeutic approaches for MS.

Entities:  

Mesh:

Year:  2012        PMID: 22450508      PMCID: PMC4435786          DOI: 10.1038/nrneurol.2012.43

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  126 in total

1.  17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.

Authors:  A Matejuk; K Adlard; A Zamora; M Silverman; A A Vandenbark; H Offner
Journal:  J Neurosci Res       Date:  2001-09-15       Impact factor: 4.164

Review 2.  Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

Authors:  R R Voskuhl; K Palaszynski
Journal:  Neuroscientist       Date:  2001-06       Impact factor: 7.519

3.  The natural history of secondary progressive multiple sclerosis.

Authors:  Marcus Koch; Elaine Kingwell; Peter Rieckmann; Helen Tremlett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-16       Impact factor: 10.154

4.  Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.

Authors:  Laura Garay; Maria Claudia Gonzalez Deniselle; Lobke Gierman; Maria Meyer; Analia Lima; Paulina Roig; Alejandro F De Nicola
Journal:  Neuroimmunomodulation       Date:  2008-07-29       Impact factor: 2.492

5.  Sex differences in cytokine responses to myelin peptides in multiple sclerosis.

Authors:  Clara M Pelfrey; Anne C Cotleur; Jar-Chi Lee; Richard A Rudick
Journal:  J Neuroimmunol       Date:  2002-09       Impact factor: 3.478

6.  The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.

Authors:  S Vukusic; I Ionescu; M El-Etr; M Schumacher; E E Baulieu; C Cornu; C Confavreux
Journal:  J Neurol Sci       Date:  2009-09-15       Impact factor: 3.181

7.  Cutting edge: the Y chromosome controls the age-dependent experimental allergic encephalomyelitis sexual dimorphism in SJL/J mice.

Authors:  Karen M Spach; Melissa Blake; Janice Y Bunn; Ben McElvany; Rajkumar Noubade; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

8.  Oral contraceptives and reproductive factors in multiple sclerosis incidence.

Authors:  L Villard-Mackintosh; M P Vessey
Journal:  Contraception       Date:  1993-02       Impact factor: 3.375

9.  Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.

Authors:  Brigitte Santner-Nanan; Michael John Peek; Roma Khanam; Luise Richarts; Erhua Zhu; Barbara Fazekas de St Groth; Ralph Nanan
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  Estrogen receptor-β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease.

Authors:  Sienmi Du; Francisco Sandoval; Pauline Trinh; Elizabeth Umeda; Rhonda Voskuhl
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

View more
  85 in total

Review 1.  Cellular and molecular mechanisms of sexual differentiation in the mammalian nervous system.

Authors:  Nancy G Forger; J Alex Strahan; Alexandra Castillo-Ruiz
Journal:  Front Neuroendocrinol       Date:  2016-01-11       Impact factor: 8.606

Review 2.  Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease.

Authors:  Nicholas P Deems; Benedetta Leuner
Journal:  Front Neuroendocrinol       Date:  2020-01-24       Impact factor: 8.606

3.  Y chromosome's roles in sex differences in disease.

Authors:  Arthur P Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-30       Impact factor: 11.205

4.  Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.

Authors:  Noriko Itoh; Roy Kim; Mavis Peng; Emma DiFilippo; Hadley Johnsonbaugh; Allan MacKenzie-Graham; Rhonda R Voskuhl
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

Review 5.  An Inconvenient Variable: Sex Hormones and Their Impact on T Cell Responses.

Authors:  Melissa A Brown; Maureen A Su
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

6.  XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.

Authors:  Sienmi Du; Noriko Itoh; Sahar Askarinam; Haley Hill; Arthur P Arnold; Rhonda R Voskuhl
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

7.  Structural sex differences at disease onset in multiple sclerosis patients.

Authors:  Juan Ignacio Rojas; Francisco Sánchez; Liliana Patrucco; Jimena Miguez; Jorge Funes; Edgardo Cristiano
Journal:  Neuroradiol J       Date:  2016-08-25

Review 8.  Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-17       Impact factor: 4.147

9.  Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility.

Authors:  Abigail E Russi; Mark E Ebel; Yuchen Yang; Melissa A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

10.  Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.

Authors:  Ana Paula Kallaur; Edna Maria Vissoci Reiche; Sayonara Rangel Oliveira; Andrea Name Colado Simão; Wildea Lice de Carvalho Jennings Pereira; Daniela Frizon Alfieri; Tamires Flauzino; Caio de Meleck Proença; Marcell Alysson Batisti Lozovoy; Damacio Ramón Kaimen-Maciel; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.